United Parcel Service, Inc. Message Board

e7navy1999 162 posts  |  Last Activity: Jun 23, 2016 10:39 PM Member since: Jan 21, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Murphy continued, “During the quarter, we found that recent data from methotrexate exposure in our exVive3D Liver serves as compelling additional differentiation for our target customers. We expect these results to drive more rapid adoption going forward. Overall, our customers are pleased with the scientific results we’re providing as evidenced by the solid pace of repeat agreements, and we expect this momentum to build now that we have dedicated sale resources across the U.S. and Europe.

    Sentiment: Strong Buy

  • e7navy1999 by e7navy1999 Mar 28, 2016 1:40 PM Flag

    good trending

    Sentiment: Strong Buy

  • Reply to

    CEO Mr Murphy quoted: "...." feb 8th

    by e7navy1999 Mar 28, 2016 1:39 PM
    e7navy1999 e7navy1999 Mar 28, 2016 2:52 PM Flag

    it took a few years for THE PARADIGM SHIFT to happen between Timex and Casio time pieces, Radio-vs-TV, Horse-vs-automobile, Gas lamps -vs- electricity,

    Sentiment: Strong Buy

  • Reply to

    I think everyone

    by baronburger Mar 30, 2016 2:35 PM
    e7navy1999 e7navy1999 Mar 30, 2016 3:07 PM Flag

    "We have no men only men genetically who act like women".#$%$? I know women that are strong, stable decision makers. I would gladly put most in charge over men anyday

    Sentiment: Strong Buy

  • Reply to

    Book Value question

    by csi_banks Apr 1, 2016 4:15 PM
    e7navy1999 e7navy1999 Apr 3, 2016 8:49 PM Flag

    maybe someday SNFCA will hire a PR person that actually has concern for their shareholders. I just do not understand why the CEO and BOD would want t sell their shares at 40%+ below what is is worth? puzzling to say the least. It is like selling ones own home for peanuts. Risk with no rewards in my mind

    Sentiment: Hold

  • e7navy1999 e7navy1999 Apr 3, 2016 8:55 PM Flag

    Pls do ask why they continue to want to sell their shares at 40%+ below book? also what insanity decision is behind the 5% annual dilution? I would think that of SNFCA is really such a bargain basement great deal the likes of Berkshire would pounce on it and buy the whole tamale for $7 per share. I suspect there is some funny business accounting going on in the background

    Sentiment: Hold

  • Reply to

    Big Sky Montana

    by ournightowl Apr 1, 2016 1:43 PM
    e7navy1999 e7navy1999 Apr 4, 2016 10:02 AM Flag

    Montana Facts: Montana holds the record for the most dramatic temperature change to occur over a 24-hour period. In 1972 in Loma, the temperature rose from -54˚F to 49˚F.

    The Museum of the Rockies has one of the largest collections of dinosaur fossils on Earth. It’s also home to 13 T-Rex specimens, more than anywhere else in the world.

    In 1888, more millionaires per capita were living in Helena than any other city in the world. Most made their fortunes off of gold.

    A portion of Yellowstone National Park, the first national park in the country, is in Montana. The park has 1000-3000 earthquakes each year and is home to one of the Earth’s few super volcanos

    Montana is the 4th largest state in the US, by area. You can fit Virginia, Maryland, Delaware, Pennsylvania and New York within its borders and still have room for the District of Columbia.

    There are more cattle in Montana than there are people.

    Sentiment: Strong Buy

  • Reply to

    Big Sky Montana

    by ournightowl Apr 1, 2016 1:43 PM
    e7navy1999 e7navy1999 Apr 4, 2016 3:33 PM Flag

    we do a total submerge contest. The first person out of the water has to buy unlimited pizza for the group

  • Reply to

    interesting

    by inomorethanudo Mar 29, 2016 7:29 PM
    e7navy1999 e7navy1999 Apr 5, 2016 11:59 AM Flag

    QTWW Patents ...some are extremely valuable. Example. The leak detection internal tank shut off. I could see WPRT and FSYS wanting that patent in a wicked way

    Sentiment: Strong Buy

  • e7navy1999 by e7navy1999 Apr 6, 2016 1:48 PM Flag

    ONVO has established partnerships as of Feb 8 2016. Please feel free to add or delete from the list. I am almost certain I missed a dozen or more partnerships. I "THINK" ZenBio is replaced by Samsara?

    L'Oreal: we expect to complete Phase1 of our agreement ahead of schedule with this leader in the beauty and cosmetics market. We also expect to recognize revenue in a few months for the completion of this first part of our contract and have already begun work on the next set of deliverables.

    Merck: we continue to work on both the toxicology and custom tissue disease modeling parts of that agreement and are also pleased to announce that we have completed our earliest deliverables and recognized revenue from multiple stages of this contract.

    National Institutes of Health: Organovo announced a partnership in January that focuses on printing eye tissue for drug and disease studies

    Janssen Research and Development, a Johnson & Johnson pharmaceutical company: Janssen and Organovo did not disclose further details about the agreement.

    Yale School of Medicine: Under Methuselah's University 3D Bioprinter Program, Methuselah is donating at least $500,000 in direct funding to be divided among several institutions for Organovo bioprinter research projects. This funding will cover budgeted bioprinter costs, as well as other aspects of project execution.

    Autodesk’s Partnership With Organovo Will Lead to Printable Organs

    Organovo Holdings and ZenBio are partnering to produce 3D human tissues for drug discovery and advanced tissue therapies. ZenBio will provide validated cellular inputs for use by Organovo with its NovoGen™ bioprinting technology to enable the generation of living, 3D tissues that reproduce the architectural and functional features of tissues inside the human body

    The government of Queensland, Australia recently announced a partnership between San Diego-based Organovo and UniQuest, the commercialization arm of the University of Queensland.

    National Center for Advancing Translational Sciences (NCATS) and the National Eye Institute to advance understanding in disease progress by printing eye tissue for research.

    Organovo has partnered with Methuselah to provide 3D tissue printers (using Organovo's bioprinting)

    The Comprehensive Center for Liver and Metabolic Disease Research (CCLMDR) is a collaborative partnership between The Hamner, Hamner Bioscience Accelerator companies, Hamner partners in industry, and key University thought leaders, to leverage collective technology and expertise in liver disease research. The CCLMDR’s vision is to be the recognized global leader and ultimate collaborative research resource for the development of strategies and next-generation technologies aimed at conquering liver and liver-related metabolic diseases. The Steering Committee for the CCLMDR is headed by Dr. Paul Watkins, director of the Hamner-University of North Carolina Institute for Drug Safety Sciences, and Dr. Edward LeCluyse, associate investigator at The Hamner.

    Researchers at University of California, San Diego School of Medicine and Samsara Sciences, Inc., a wholly-owned subsidiary of Organovo Holdings, Inc., have entered into an agreement focused on the development of techniques and methods for the isolation and characterization of liver cells that will help drive new research on liver biology, drug safety and efficacy, and the treatment of liver diseases.

    Pfizer partner with Organovo: plans to fund its organ-­printing research with revenue from printing tissues to aid in drug development. The company is undertaking experiments to prove that its technology can help researchers detect drug toxicity earlier than is possible with other tests, and it is setting up partnerships with major companies, starting with the drug giant Pfizer

    The Knight Cancer Institute at Oregon Health & Science University (OHSU), a national leader in translational oncology research, and Organovo Holdings Inc. (OTCQX: ONVO) ("Organovo"), a creator and manufacturer of functional, three-dimensional human tissues for medical research and therapeutic applications, have formed a collaboration to develop more clinically predictive in vitro three-dimensional cancer models that will ultimately advance discovery of novel cancer therapeutics.

    Sentiment: Strong Buy

  • e7navy1999 by e7navy1999 Apr 6, 2016 2:01 PM Flag

    Home sick today with the flu. Searching ONVO on Google Earth to stalk what kind of cars ONVO employees drive. I found that Otonomy shares the same address as ONVO now. 6 months ago it did not. Otonomyjust announced: Initiates Patient Enrollment in Second Phase 3 Clinical Trial of OTO-104 in Ménière’s Disease. Might be something coming out about onvo early drug testing with eyes

    Sentiment: Strong Buy

  • e7navy1999 e7navy1999 Apr 6, 2016 2:09 PM Flag

    Yeah I need to take a codine pill to relax. The CFO kept all his shares and is signed on to consult until the end of 2017. Sweet deal and plenty of time to train a new bean counter. Mr Murphy did him a right

  • Reply to

    Interesting Find

    by e7navy1999 Apr 6, 2016 2:01 PM
    e7navy1999 e7navy1999 Apr 6, 2016 2:15 PM Flag

    OTO-104 for Ménière’s disease has been granted Fast Track designation by the FDA. this is Ear not eye...my bad

  • Reply to

    Interesting Find

    by e7navy1999 Apr 6, 2016 2:01 PM
    e7navy1999 e7navy1999 Apr 6, 2016 2:32 PM Flag

    I actually just bought some OTIC. If ONVO did already test the drug against liver and kidney assays then the phase 3 is going to pass. If so OTIC will pop to over $40 from $17. They have three other ear drugs in the pipeline

    Sentiment: Strong Buy

  • Reply to

    Interesting Find

    by e7navy1999 Apr 6, 2016 2:01 PM
    e7navy1999 e7navy1999 Apr 6, 2016 6:22 PM Flag

    It is risky. Lots of short, not much in income, extremely high market cap. It is worth 100 shares at least

  • Reply to

    Interesting Find

    by e7navy1999 Apr 6, 2016 2:01 PM
    e7navy1999 e7navy1999 Apr 7, 2016 12:00 PM Flag

    Hey moo. What is your guess? Do you think OTIC had their product checked by ONVO since they are in the same building? If I were the CEO of either company I would at least ask off the record and see how it all turns out

    Sentiment: Strong Buy

  • Reply to

    Glassdoor

    by twojugglers Apr 7, 2016 8:54 AM
    e7navy1999 e7navy1999 Apr 7, 2016 5:03 PM Flag

    me2, I wrote and request a ball cap and tee shirt. Was told they did not have anything but that was last year. I am going to try again...right now actually

    Sentiment: Strong Buy

  • e7navy1999 by e7navy1999 Apr 7, 2016 5:15 PM Flag

    for us charters $2.50 is near in sight...actually slightly overdue by a couple of days..

  • Reply to

    Please Google Onvo Investor Forum

    by cashmoo2 Feb 10, 2016 9:44 PM
    e7navy1999 e7navy1999 Apr 8, 2016 11:34 AM Flag

    I wrote IR and requested a tee shirt. Waiting for a surprise in the mail...I will let yah all know of the Forum how it goes

  • Reply to

    Interesting Find

    by e7navy1999 Apr 6, 2016 2:01 PM
    e7navy1999 e7navy1999 Apr 8, 2016 9:07 PM Flag

    i bet they do. If I were a CEO of either company I would a least ask for a test..on the house plus a few beers

UPS
104.41-2.81(-2.62%)Jun 24 4:01 PMEDT